Buy Livagen: Analytical Standards and Preclinical Sourcing
For laboratory investigators seeking to buy Livagen (KEDP) for chromatin and gene expression assays, sourcing high-purity, verified material is essential for experimental accuracy. PX1 Research delivers USA-manufactured, lot-traced Livagen backed by analytical HPLC-MS data and strict endotoxin limits. Every vial is prepared under GMP-compliant conditions to support reproducible preclinical research.
Quick answer
For laboratory investigators seeking to buy Livagen (KEDP) for chromatin and gene expression assays, sourcing high-purity, verified material is essential for experimental accuracy. PX1 Research delivers USA-manufactured, lot-traced Livagen backed by analytical HPLC-MS data and strict endotoxin limits. Every vial is prepared under GMP-compliant conditions to support reproducible preclinical research.
Key takeaways
- When principal investigators prepare to [buy Livagen](/product/livagen) for experimental applications, obtaining a fully characterized compound with lot-specific documentation is vital.
- Livagen is classified as a short synthetic tetrapeptide consisting of L-lysyl-L-glutamyl-L-aspartyl-L-proline (KEDP).
- Preclinical investigation into Livagen focuses heavily on its capacity to interact with nuclear chromatin.
- Literature evaluating Livagen in preclinical aging models highlights its action on immunocompetent cells.
Direct Sourcing Direct Answer: Sourcing High-Purity Livagen for Preclinical Research
When principal investigators prepare to buy Livagen for experimental applications, obtaining a fully characterized compound with lot-specific documentation is vital. Livagen is a synthetic short bioregulatory peptide comprised of the amino acid sequence Lys-Glu-Asp-Pro (KEDP). Designed strictly for laboratory research use, PX1 Research provides high-purity Livagen synthesized in ISO 17025 accredited and GMP-compliant domestic facilities, verified by independent HPLC and mass spectrometry testing to ensure consistent molecular mass and purity exceeding 98%.
Sourcing reference-grade peptides requires complete supply chain transparency. Every batch of Livagen supplied by PX1 Research includes a downloadable Certificate of Analysis (COA) detailing analytical purity, sequence confirmation, and bacterial endotoxin levels. Qualified academic, clinical, and industrial researchers can obtain this peptide through our direct catalog or set up institutional purchasing via a wholesale research account.
Molecular Structure and Biochemical Profile of Livagen (KEDP)
Livagen is classified as a short synthetic tetrapeptide consisting of L-lysyl-L-glutamyl-L-aspartyl-L-proline (KEDP). Derived structurally from peptide fractions initially identified in tissue extracts, Livagen belongs to a group of low-molecular-weight peptide bioregulators. Its compact structure allows it to interact directly with nuclear components in cellular models, serving as a primary target of investigation in chromatin dynamics and nuclear-cytoplasmic signaling.
The short primary sequence of KEDP grants the molecule high stability in aqueous solutions compared to larger polypeptide chains, though proper physical handling remains necessary to prevent enzymatic degradation during cell culture preparation. The terminal proline residue provides structural rigidity, which preclinical literature suggests plays a role in receptor binding affinity and resistance to non-specific exopeptidase cleavage in vitro. Investigators cataloging sequence-specific short peptides can view the complete line of synthetic compounds in our all research peptides catalog.
Epigenetic Mechanisms: Chromatin Remodeling and Heterochromatin Activation
Preclinical investigation into Livagen focuses heavily on its capacity to interact with nuclear chromatin. In vitro studies using human lymphocyte cultures and fibroblast models demonstrate that KEDP can induce decondensation of pericentromeric heterochromatin. By promoting a transition from densely packed heterochromatin to accessible euchromatin, Livagen allows RNA polymerase complexes greater access to silent genomic regions.
In vitro assays indicate that this chromatin remodeling effect is accompanied by alterations in histone acetylation patterns. By modulating the interaction between histone proteins and DNA strands, Livagen facilitates the reactivation of silenced genes associated with cellular repair and protein synthesis in senescent cell lines. Researchers exploring these chromatin dynamics can access supporting data and peer-reviewed summaries in the PX1 peptide research database.
Preclinical Literature: Cellular Aging and Immune Cell Responsiveness
Literature evaluating Livagen in preclinical aging models highlights its action on immunocompetent cells. In vitro assays using lymphocytes derived from elderly animal and human tissue donors reveal that exposure to KEDP restores expression levels of key cell-surface markers and ribosomal genes that typically decline with age. These observations suggest that Livagen operates through gene-specific transcriptional reactivation rather than non-specific cellular stimulation.
Rodent tissue models have further examined the influence of Livagen on protein synthesis rates within hepatocytes and myocardial cells. Preclinical data show that exposure to short bioregulatory peptides maintains protein translation efficiency under induced metabolic stress or oxidative challenge. These findings establish Livagen as a key reference compound for investigating cellular resilience and lifespan extension mechanisms in vitro.
Comparative Analysis: Livagen vs. Epitalon vs. Vilon
Livagen operates within a broader family of short synthetic bioregulatory peptides, requiring comparative evaluation to select the appropriate molecule for specific experimental designs. While Livagen (KEDP) targets chromatin decondensation and lymphocyte marker expression, Epitalon (Ala-Glu-Asp-Gly) is predominantly investigated for its influence on telomerase activity and telomere elongation in somatic cells. Meanwhile, Vilon (Lys-Glu) represents a dipeptide fragment that focuses primarily on early-stage immune signaling pathways.
Understanding these distinct mechanisms is crucial when designing multi-compound comparative trials or evaluating synergism in cell culture models. For a comprehensive overview of sequence-specific mechanisms among short chain peptides, consult our detailed guide on bioregulatory peptide mechanisms.
Reconstitution Protocols and Laboratory Handling Standards
Achieving reproducible results with Livagen requires strict adherence to sterile reconstitution techniques. The lyophilized peptide powder should be brought to room temperature inside a laminar flow hood before reconstitution to prevent condensation inside the vial. Reconstitution should be performed using sterile bacteriostatic water or laboratory-grade phosphate-buffered saline (PBS, pH 7.4), depending on the requirements of the downstream in vitro or enzymatic assay.
To reconstitute, gently inject the chosen solvent down the glass wall of the vial rather than directly onto the lyophilized cake. Allow the cake to hydrate naturally before gently swirling the vial; vigorously shaking or vortexing the solution can cause mechanical shear stress and peptide denaturation. Detailed step-by-step procedures are outlined in our peptide reconstitution guide.
Storage Stability, Aliquoting, and Cold-Chain Integrity
In its lyophilized form, PX1 Research Livagen maintains molecular integrity when stored at -20°C for short-term projects or -80°C for long-term storage, protected from light and moisture. Lyophilized vials should remain sealed until immediate use to preserve vacuum integrity and prevent ambient hydration.
Once reconstituted into aqueous solution, Livagen should be divided into single-use experimental aliquots using polypropylene microcentrifuge tubes to avoid repeated freeze-thaw cycles, which degrade peptide bonds over time. Reconstituted solutions stored at 4°C should be utilized within 7 to 14 days, while frozen aliquots at -20°C maintain stability for up to 3 to 6 months depending on solvent pH and concentration.
Analytical Quality Controls: HPLC, Mass Spectrometry, and Endotoxin Limits
To ensure experimental validity, PX1 Research Subjects every manufactured batch of Livagen to rigorous analytical verification. Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) confirms chemical purity, verifying that the main peak accounts for >98% of total integrated area with no interfering synthesis side-products or truncated sequences.
Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact molecular mass of the KEDP peptide, matching its theoretical monoisotopic mass. Furthermore, every lot undergoes Chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure bacterial endotoxin levels remain strictly under <0.01 EU/mg. This guarantees that cell culture treatments are free from lipopolysaccharide-induced inflammatory artifacts.
Domestic USA Manufacturing and Express Dispatch Logistics
PX1 Research operates exclusively within certified USA-based manufacturing facilities adhering to strict ISO 17025 and cGMP standards. By controlling synthesis, purification, lyophilization, and analytical testing domestically, we eliminate supply chain delays and foreign batch variability that compromise laboratory schedules.
All orders for research peptides placed Monday through Friday are processed and dispatched standard with same-day shipping from our primary distribution hubs in California and Arizona. Vials are packaged in specialized protective insulated containers to maintain structural stability during transit, ensuring ready-to-use compounds upon delivery to your research institution.
Frequently Asked Questions
Where can researchers buy Livagen with verified purity documentation?
Researchers can buy Livagen directly from PX1 Research. Every lot is manufactured in the USA and includes downloadable HPLC and Mass Spectrometry reports verifying purity levels exceeding 98%.
What is the sequence and chemical structure of Livagen?
Livagen is a synthetic tetrapeptide with the primary amino acid sequence Lys-Glu-Asp-Pro (KEDP) and a molecular formula of C19H31N5O9.
What preclinical research applications involve Livagen?
In vitro and animal model studies investigate Livagen for its involvement in heterochromatin decondensation, gene transcription modulation, lymphocyte reactivation, and cellular aging mechanisms.
How is lyophilized Livagen stored prior to reconstitution?
Unopened, lyophilized Livagen vials should be stored at -20°C or -80°C in a desiccated environment protected from light exposure.
What solvent is recommended to reconstitute Livagen for laboratory assays?
Livagen is typically reconstituted using sterile bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4), depending on the sensitivity of the downstream in vitro system.
Does PX1 Research perform endotoxin testing on Livagen?
Yes. Every lot of Livagen undergoes LAL endotoxin testing to guarantee endotoxin limits remain below <0.01 EU/mg, preventing non-specific immune activation in cell culture models.
How does Livagen differ structurally from Epitalon?
Livagen consists of the amino acid sequence KEDP (Lys-Glu-Asp-Pro), whereas Epitalon consists of AEDG (Ala-Glu-Asp-Gly). While both are bioregulatory short peptides, they target distinct molecular pathways.
Are batch-specific Certificates of Analysis available for Livagen?
Yes. PX1 Research provides lot-specific Certificates of Analysis (COA) detailing RP-HPLC purity profiles, mass spectrometry verification, and endotoxin content for every order.
Can institutions setup wholesale accounts to buy Livagen in bulk?
Yes. Academic labs, biotechnology firms, and institutional buyers can apply for a wholesale account with PX1 Research to access tiered bulk pricing and dedicated account management.
What are the shipping timelines when ordering Livagen from PX1 Research?
Orders placed Monday through Friday ship same-day from our facility locations in California and Arizona via express carrier logistics.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.